ストックスクリーナーアプリを入手
167.35
4.46%
7.14
アフターアワーズ：
164.01
-3.34
-2.00%
前日終値:
$160.21
開ける：
$161.54
24時間の取引高:
1.15M
Relative Volume:
0.92
時価総額：
$22.97B
収益：
$1.96B
当期純損益:
$-253.24M
株価収益率:
-87.62
EPS:
-1.91
ネットキャッシュフロー:
$94.06M
1週間 パフォーマンス:
+2.69%
1か月 パフォーマンス:
-0.11%
6か月 パフォーマンス:
+20.65%
1年 パフォーマンス:
+32.50%
1日の値動き範囲:
$160.59
$167.91
1週間の範囲:
$157.43
$167.91
52週間の値動き範囲:
$117.27
$183.00
Natera Inc Stock (NTRA) Company Profile
NTRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
167.35 | 21.99B | 1.96B | -253.24M | 94.06M | -1.91 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st
Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st
Chart based exit strategy for Natera Inc.2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
How institutional ownership impacts Natera Inc. stock2025 Valuation Update & Safe Capital Growth Tips - newser.com
Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Combining machine learning predictions for Natera Inc.Market Performance Summary & Weekly Breakout Stock Alerts - newser.com
Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative
Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com South Africa
Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT - BioSpace
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing - Investing.com Nigeria
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera (NTRA) sec. Rabinowitz sells $221k in shares By Investing.com - Investing.com Australia
Natera CFO Brophy sells $403,673 in shares By Investing.com - Investing.com South Africa
Natera CEO Chapman sells $3.7m in stock - Investing.com India
Natera (NTRA) sec. Rabinowitz sells $221k in shares - Investing.com India
Natera CFO Brophy sells $403,673 in shares - Investing.com India
Natera Inc: president Moshkevich sells $479k in stock By Investing.com - Investing.com South Africa
Natera Inc: president Moshkevich sells $479k in stock - Investing.com
Natera, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Why Natera’s Stock is Gaining Attention - TipRanks
Natera (NTRA) Achieves Key Enrollment Milestone in EXPAND Trial - GuruFocus
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing By Investing.com - Investing.com South Africa
Is Natera Inc. building a consolidation baseFed Meeting & Daily Chart Pattern Signal Reports - newser.com
Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer - BioSpace
Natera’s ctDNA test outperforms standard markers in testicular cancer By Investing.com - Investing.com Nigeria
Natera’s ctDNA test outperforms standard markers in testicular cancer - Investing.com India
Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows - BioSpace
Natera, Inc. (NASDAQ:NTRA) Given Average Rating of "Buy" by Brokerages - MarketBeat
GAMMA Investing LLC Acquires 411 Shares of Natera, Inc. $NTRA - Defense World
Natera's president sells shares worth $117,861 - MSN
Natera’s Signatera test shows strong results for uterine cancer monitoring By Investing.com - Investing.com Canada
Natera’s Signatera test shows strong results for uterine cancer monitoring - Investing.com
SWS Partners Reduces Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NTRA) Stock Analysis: Evaluating the 18.92% Upside Potential in Healthcare Diagnostics - DirectorsTalk Interviews
Why Natera Inc. stock remains on buy lists2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com
Natera, Inc. (NTRA) Stock Analysis: 18.92% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Natera, Inc. $NTRA Shares Acquired by Farther Finance Advisors LLC - MarketBeat
CareDx Asks 3rd Circ. To Rethink $45M False Ad Case - Law360
Life Beyond the Redwoods: Ciara Bolt at UC San Francisco and NateraUC Santa Cruz - UC Santa Cruz - News
Wealth Enhancement Advisory Services LLC Has $4.58 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Park Avenue Securities LLC Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. Stock Hits Day Low Amid Price Pressure at $163.65 - Markets Mojo
Stocks making big moves yesterday: Acadia Healthcare, Tesla, THOR Industries, Natera, and P10 - The Globe and Mail
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
0.89%
2.01%
大文字化:
|
ボリューム (24 時間):